OSL •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/05/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeOSL
Market Capitalization922.37 mln
Float21.97 mln
Earnings Date08/20/2026
EPS
1.68
Decent
P / E
12.14
Fair value
Piotroski F-Score
9
/ 9
Exceptional
Beneish M-Score
-1.56
Likely manipulated
Relative Strength
14
/ 100
Significantly lagging
Debt / Equity
0.06
Debt-free
Business Description
Founded over 50 years ago and headquartered in Oslo, Norway, Vistin Pharma ASA is a global manufacturer and supplier of key ingredients used in the production of medicines. Through its main operating subsidiary, the company specializes in metformin hydrochloride, a widely used compound in diabetes treatment, supplied in forms that make it easy for drug manufacturers to work with.
